Delivery Order SPE2DB22D6029-SPE2DB25FLVZC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- The Defense Logistics Agency awarded a $3,616.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units) on September 18, 2025, with completion expected by September 19, 2025. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,992.30 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) with a firm fixed price and an ultimate completion date of July 3, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,165.31 on August 8, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on September 15, 2025, with a ceiling value of $42,385.52. This firm fixed-price delivery order, which is expected to be completed by September 16, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded without set-aside provisions, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100s, with a ceiling value of $11,707.25. The delivery order represents a firm fixed price, competitive award with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVZCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) valued at $2,656.40 under a firm fixed-price contract. This non-set-aside delivery order, awarded on September 16, 2025, represents a single pharmaceutical procurement with an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management (SAM.gov). This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The Defense Health Agency, U.S. Coast Guard, and other government healthcare systems utilize this flexible contract vehicle for their pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/16/25 |